Evidence map›Paper›PMID 25865928›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex.

Michael D Scofield, Heather Trantham-Davidson, Marek Schwendt, Kah-Chung Leong, Jamie Peters, Ronald E See, Carmela M Reichel

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Repeated methamphetamine administration produces cognitive deficits through augmentation of GABAergic synaptic transmission in the prefrontal cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Perirhinal Cortex mGlu5 Receptor Activation Reduces Relapse to Methamphetamine Seeking by Restoring Novelty Salience.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Michael D ScofieldDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC, USA.
Heather Trantham-DavidsonDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC, USA.
Marek SchwendtDepartment of Psychology, University of Florida, Gainesville, FL, USA.
Kah-Chung LeongDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC, USA.
Jamie PetersDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC, USA.
Ronald E SeeDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC, USA.
Carmela M ReichelDepartment of Neurosciences, Medical University of South Carolina, Charleston, SC, USA.
Medical University of South Carolina · USUniversity of Florida · US

Funding

DRUG ABUSE TRAINING PROGRAMT32DA007288 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Christopher W Cowan, Rachel Penrod-Martin · 1991 to 2026
$11.8M
Corticostriatal Neuroplasticity and Cognition in Methamphetamine AddictionR01DA033049 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI SCOFIELD, MICHAEL DAVID · 2012 to 2022
$3.4M
MUSC FACIL EXPANSION &RENOV: SLE C06RR015455 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND, JOHN R · 2002 to 2002
$2.0M
NCRR NIH HHS C06 RR015455NIDA NIH HHS DA007288NIDA NIH HHS DA033049NIDA NIH HHS R01 DA033049NIDA NIH HHS T32 DA007288
6 · The paper itself

Abstract

Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in rats. Recognition of novelty depends upon intact perirhinal (pRh) cortex function, which is compromised by meth-induced downregulation of GluN2B-containing N-methyl-D-aspartate (NMDA) receptors. NMDA receptors containing this subunit have a critical role in pRh long-term depression (LTD), one of the primary physiological processes thought to underlie object recognition memory. We hypothesized that meth-induced downregulation of GluN2B receptors would compromise pRh LTD, leading to loss of NOR memory. We found that meth self-administration resulted in an inability to induce pRh LTD following 1 Hz stimulation, an effect that was reversed with bath application of the NMDA receptor partial agonist D-cycloserine (DCS). In addition, pRh microinfusion of DCS restored meth-induced memory deficits. Furthermore, blockade of GluN2B-containing NMDA receptors with Ro 25-6981 prevented DCS restoration of pRh LTD in meth subjects. Thus, targeting pRh LTD may be a promising strategy to treat meth-induced cognitive impairment.

Indexed as

Amphetamine-Related DisordersAnimalsCentral Nervous System StimulantsCycloserineExcitatory Amino Acid AgentsLong-Term Synaptic DepressionMaleMemory DisordersMethamphetaminePhenolsPiperidinesRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateRecognition, PsychologySelf AdministrationTissue Culture TechniquesCentral Nervous System StimulantsCycloserineExcitatory Amino Acid AgentsMethamphetamineNR2B NMDA receptorPhenolsPiperidinesReceptors, N-Methyl-D-AspartateRo 25-6981

Identifiers

PMID25865928
PMCPMC4569960
OpenAlexW1987964047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.